Invesco
DFTX

Invesco’s Definium Therapeutics DFTX Stock Holding History

Invesco’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.3M Buy
91,338
+3,217
+4% +$79.5K ﹤0.01% 2282
2026
Q1 		$1.67M Buy
88,121
+34,739
+65% +$590K ﹤0.01% 2628
2025
Q4 		$715K Buy
53,382
+13,253
+33% +$164K ﹤0.01% 3053
2025
Q3 		$473K Buy
40,129
+1,666
+4% +$15.5K ﹤0.01% 3240
2025
Q2 		$250K Sell
38,463
-637
-2% -$4.19K ﹤0.01% 3440
2025
Q1 		$229K Sell
39,100
-2,300
-6% -$16.5K ﹤0.01% 3454
2024
Q4 		$288K Buy
41,400
+4,564
+12% +$31.4K ﹤0.01% 3423
2024
Q3 		$210K Buy
36,836
+395
+1% +$2.75K ﹤0.01% 3505
2024
Q2 		$263K Buy
+36,441
New +$319K ﹤0.01% 3544
2022
Q3 		– Sell
-1,040
Closed -$10K – 4024
2022
Q2 		$10K Sell
1,040
-7,884
-88% -$99.8K ﹤0.01% 4028
2022
Q1 		$149K Sell
8,924
-876
-9% -$15.2K ﹤0.01% 3820
2021
Q4 		$203K Sell
9,800
-3,509
-26% -$112K ﹤0.01% 3770
2021
Q3 		$465K Buy
13,309
+3,113
+31% +$135K ﹤0.01% 3463
2021
Q2 		$528K Buy
+10,196
New +$535K ﹤0.01% 3394

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Invesco's DFTX Position: Q2 2026 in Review

Invesco increased its Definium Therapeutics (DFTX) stake by 3.7% in Q2 2026, buying an estimated $79.5K and bringing the position to 91,338 shares worth $4.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2282.

Invesco first reported a position in DFTX in Q2 2021 and has held it in 14 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Invesco held 91,338 shares of Definium Therapeutics worth $4.3M as of Q2 2026.
  • Invesco bought 3,217 Definium Therapeutics shares in Q2 2026, an estimated $79.5K.
  • Definium Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2282 holding.
  • Invesco first reported a position in Definium Therapeutics in Q2 2021 and has held it in 14 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.